FDA targets Lilly, Novartis, BMS and more in deluge of marketing letters Fierce Pharma FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz AP News Hims & Hers Stock: How It Found Itself in the FDA’s Crosshairs Barron’s Opinion | I Run the F.D.A. Pharma Ads Are Hurting Americans. The New York Times U.S. FDA sends drug advertising warning …
Read More »